These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 29402314)

  • 1. Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low- and middle-income countries.
    Luz A; Santatiwongchai B; Pattanaphesaj J; Teerawattananon Y
    Health Res Policy Syst; 2018 Feb; 16(1):4. PubMed ID: 29402314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries' Health Economics Practitioners: A Commentary.
    Adeagbo CU; Rattanavipapong W; Guinness L; Teerawattananon Y
    Value Health; 2018 May; 21(5):569-572. PubMed ID: 29753354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.
    Wilkinson T; Sculpher MJ; Claxton K; Revill P; Briggs A; Cairns JA; Teerawattananon Y; Asfaw E; Lopert R; Culyer AJ; Walker DG
    Value Health; 2016 Dec; 19(8):921-928. PubMed ID: 27987641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines.
    Thiboonboon K; Santatiwongchai B; Chantarastapornchit V; Rattanavipapong W; Teerawattananon Y
    Appl Health Econ Health Policy; 2016 Dec; 14(6):659-672. PubMed ID: 27475634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to conducting economic evaluation studies of Gulf Cooperation Council (GCC) countries: a survey of researchers.
    Almazrou SH; Alaujan SS; Al-Aqeel SA
    Health Res Policy Syst; 2021 May; 19(1):71. PubMed ID: 33933093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quest for a framework for sustainable and institutionalised priority-setting for health research in a low-resource setting: the case of Zambia.
    Kapiriri L; Chanda-Kapata P
    Health Res Policy Syst; 2018 Feb; 16(1):11. PubMed ID: 29452602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake.
    Merlo G; Page K; Ratcliffe J; Halton K; Graves N
    Appl Health Econ Health Policy; 2015 Jun; 13(3):303-9. PubMed ID: 25288052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income Countries.
    Sweeney S; Vassall A; Foster N; Simms V; Ilboudo P; Kimaro G; Mudzengi D; Guinness L
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):42-52. PubMed ID: 26774106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Institutional capacity to generate and use evidence in LMICs: current state and opportunities for HPSR.
    Shroff ZC; Javadi D; Gilson L; Kang R; Ghaffar A
    Health Res Policy Syst; 2017 Nov; 15(1):94. PubMed ID: 29121958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embedding rapid reviews in health policy and systems decision-making: Impacts and lessons learned from four low- and middle-income countries.
    Robson RC; Thomas SM; Langlois ÉV; Mijumbi R; Kawooya I; Antony J; Courvoisier M; Amog K; Marten R; Chikovani I; Nambiar D; Ved RR; Bhaumik S; Balqis-Ali NZ; Sararaks S; Md Sharif S; Kangwende RA; Munatsi R; Straus SE; Tricco AC
    Health Res Policy Syst; 2023 Jun; 21(1):45. PubMed ID: 37280697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable?
    Yothasamut J; Tantivess S; Teerawattananon Y
    Value Health; 2009; 12 Suppl 3():S26-30. PubMed ID: 20586976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions.
    Iribarren SJ; Cato K; Falzon L; Stone PW
    PLoS One; 2017; 12(2):e0170581. PubMed ID: 28152012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing the National Knowledge Platform in India: a policy and institutional analysis.
    Sriram V; Bennett S; Raman VR; Sheikh K
    Health Res Policy Syst; 2018 Feb; 16(1):13. PubMed ID: 29463256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence map of knowledge translation strategies, outcomes, facilitators and barriers in African health systems.
    Edwards A; Zweigenthal V; Olivier J
    Health Res Policy Syst; 2019 Feb; 17(1):16. PubMed ID: 30732634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health policy and systems research agendas in developing countries.
    Gonzalez-Block MA
    Health Res Policy Syst; 2004 Aug; 2(1):6. PubMed ID: 15296509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to formalization of the informal waste sector into municipal solid waste management systems in low- and middle-income countries: Review of barriers and success factors.
    Aparcana S
    Waste Manag; 2017 Mar; 61():593-607. PubMed ID: 28038906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators.
    Hopman HA; Crowcroft NS; Cesuroglu T; Langley JM
    Vaccine; 2020 Mar; 38(11):2512-2518. PubMed ID: 32057578
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.